← Eichor
Study identifier: NCT04809506 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Identification of New Biomarkers for the Prediction of Cardiovascular Events

Condition: Cardiovascular Diseases  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants1500
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The main goal of this project is to constitute a collection of biological samples, obtained through the clinical activity of the Centre for Screening and Prevention of Atherosclerosis at Toulouse University Hospital, managing patients in primary or secondary prevention for cardiovascular (CV) diseases. The main objective is to validate new biomarkers with prognostic value regarding the onset of future CV events. Besides, the biological collection will enable patho-physiological studies on atherosclerosis related diseases.

This description comes directly from the study's public registry record.

Talk to the study team

Jean Ferrières, MD PhD  ·  562323728  ·  ferrieres.j@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04809506